U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
169951169951Anecortave Acetate Risk Reduction Trial (AART)TerminatedNo Results AvailableAMDDrug: Anecortave Acetate Sterile Suspension, 30 mg/mL|Drug: Anecortave Acetate Sterile Suspension, 60 mg/mL|Other: Anecortave Acetate Vehiclehttps://ClinicalTrials.gov/show/NCT00332657
169952169952Smoking Cessation Medications: Efficacy, Mechanisms and AlgorithmsCompletedHas ResultsNicotine DependenceDrug: nicotine patch|Drug: nicotine lozenge|Drug: nicotine patch + nicotine lozenge|Drug: bupropion|Drug: bupropion + lozenge|Drug: placebohttps://ClinicalTrials.gov/show/NCT00332644
169953169953High-Dose N-Acetylcysteine in Cardiac SurgeryCompletedNo Results AvailableCardiac Surgery and Cardiopulmonary BypassDrug: N-acetylcysteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00332631
169954169954Efficacy Study of Oxygenated Glycerol Triesters to Treat XerostomiaCompletedNo Results AvailableXerostomiaDevice: OXYGENATED GLYCEROL TRIESTERShttps://ClinicalTrials.gov/show/NCT00332618
169955169955N-Acetyl Cysteine Plus Naltrexone in Methamphetamine DependenceCompletedHas ResultsMethamphetamine DependenceDrug: Naltrexone plus N-Acetyl Cysteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00332605
169956169956Intragastric and Peritoneal Microdialysis in Infants With Necrotizing Enterocolitis (NEC)CompletedNo Results AvailableNecrotizing Enterocolitishttps://ClinicalTrials.gov/show/NCT00332592
169957169957Double-Blind Naltrexone in KleptomaniaCompletedHas ResultsKleptomaniaDrug: Naltrexone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00332579
169958169958Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/HibCompletedNo Results AvailableHepatitis B|Diphtheria|Pertussis|Haemophilus Influenzae Type b Diseases|TetanusBiological: DTPw-HBV/Hib Kft vaccine GSK323527A|Biological: Tritanrixâ„¢-HepB/Hiberixâ„¢https://ClinicalTrials.gov/show/NCT00332566
169959169959Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral EstrogenCompletedNo Results AvailableVasomotor Symptoms|Endometrial SafetyDrug: Raloxifene|Drug: medroxyprogesterone acetate|Drug: estrogen|Drug: 17 beta estradiolhttps://ClinicalTrials.gov/show/NCT00332553
169960169960Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableOcular HypertensionDrug: bimatoprost/timolol fixed combinationhttps://ClinicalTrials.gov/show/NCT00332540
169961169961Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient CareCompletedNo Results AvailableInpatients|Patient ReadmissionBehavioral: telephone call by a pharmacisthttps://ClinicalTrials.gov/show/NCT00332514
169962169962Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Technosphere Insulin|Drug: Metformin & Secretagogues|Drug: Technosphere Insulin & Metforminhttps://ClinicalTrials.gov/show/NCT00332488
169963169963A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant RecipientsCompletedHas ResultsLiver TransplantationDrug: Cyclosporine (Sandimmun® i.v.)|Drug: Cyclosporine (Sandimmun® Optoral)https://ClinicalTrials.gov/show/NCT00332462
169964169964Early Breast Feeding and Glucose Levels in High Risk NewbornsRecruitingNo Results AvailableNeonatal Hypoglycemiahttps://ClinicalTrials.gov/show/NCT00332449
169965169965Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableOcular HypertensionDrug: brimonidine/timolol fixed combinationhttps://ClinicalTrials.gov/show/NCT00332436
169966169966Intravenous Voriconazole in Patients With Renal CompromiseActive, not recruitingNo Results AvailableRenal Transplanthttps://ClinicalTrials.gov/show/NCT00332410
169967169967The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent RestenosisCompletedNo Results AvailableCoronary DiseaseDevice: Rapamycin-eluting Stent|Device: Zotarolimus-eluting Stent|Device: Rapamycin-eluting Stenthttps://ClinicalTrials.gov/show/NCT00332397
169968169968Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableOcular HypertensionDrug: brimonidine/timolol fixed combinationhttps://ClinicalTrials.gov/show/NCT00332384
169969169969COMPACT - COMbining Plasma-filtration and Adsorption Clinical TrialTerminatedNo Results AvailableShock, SepticDevice: CPFA (Coupled Plasma Filtration Adsorption)https://ClinicalTrials.gov/show/NCT00332371
169970169970Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableOcular HypertensionDrug: brimonidine/timolol fixed combinationhttps://ClinicalTrials.gov/show/NCT00332345
169971169971Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in PsoriasisCompletedHas ResultsPsoriasisBiological: etanercepthttps://ClinicalTrials.gov/show/NCT00332332
169972169972Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury PatientsTerminatedNo Results AvailableIncontinence, Urinary and Urinary Bladder, Overactive|Overactive BladderDrug: GW679769https://ClinicalTrials.gov/show/NCT00332319
169973169973Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentActive, not recruitingNo Results AvailableTuberculosis|Human Immunodeficiency Virus InfectionsDrug: Didanosine, Lamivudine, Efavirenz|Drug: Didanosine, Lamivudine, Nevirapinehttps://ClinicalTrials.gov/show/NCT00332306
169974169974AL-15469A for the Treatment of Bacterial ConjunctivitisCompletedNo Results AvailableBacterial ConjunctivitisDrug: Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%|Drug: Moxifloxacin hydrochloride ophthalmic solution 0.5% as basehttps://ClinicalTrials.gov/show/NCT00332293
169975169975Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus PlaceboTerminatedNo Results AvailableGastrointestinal Cancer|Prostate Cancer|Genital Neoplasms, FemaleDrug: AMT2003https://ClinicalTrials.gov/show/NCT00332280
169976169976Cerebral Blood Flow and Metabolism During Hypoxia and EndotoxemiaCompletedNo Results AvailableHypoxia|Endotoxemia|HealthyProcedure: Endotoxin infusion, Normobaric hypoxiahttps://ClinicalTrials.gov/show/NCT00332267
169977169977Study to Prevent Cartilage Damage Following Acute Knee Injury.CompletedNo Results AvailableKnee InjuryDrug: Anakinrahttps://ClinicalTrials.gov/show/NCT00332254
169978169978Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)CompletedHas ResultsAutistic DisorderDrug: Aripiprazole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00332241
169979169979Behavioral Naltrexone Therapy: A Novel Treatment for Heroin DependenceCompletedNo Results AvailableOpiate DependenceDrug: depot naltrexone|Behavioral: Compliance enhancement (CE)|Drug: BNThttps://ClinicalTrials.gov/show/NCT00332228
169980169980A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.TerminatedNo Results AvailableCystic FibrosisDrug: Inhaled Sodium Pyruvatehttps://ClinicalTrials.gov/show/NCT00332215

* Görseller ve İçerik tekif hakkına sahip olabilir